The Bio Report

563 Episodes

1. Improving Healthcare by Addressing the Most Challenging Patients

   Published: 8/4/2016
2. The Case for Chasing Unpopular Indications

   Published: 7/28/2016
3. Improving Drug Development through Better Use of Biomarkers

   Published: 7/21/2016
4. Measuring the Value of Incubators and Accelerators

   Published: 7/14/2016
5. Enlisting New and Old Tools to Combat Antibiotic Resistance

   Published: 7/7/2016
6. Advancing Cancer Care with New Diagnostic Tools

   Published: 6/30/2016
7. A Biotech Reinvents Itself and How to Price Drugs

   Published: 6/23/2016
8. Using Technology to Modernize Preclinical Development

   Published: 6/16/2016
9. Can the Biotech Industry Stay on Track through Innovative Pricing

   Published: 6/8/2016
10. Wall Street Turns Its Eyes to ASCO

    Published: 6/2/2016
11. Understanding the Disease It Never Was on House

    Published: 5/26/2016
12. Why the State of Innovation Is Encouraging

    Published: 5/19/2016
13. Can Market Forces Fix Drug Pricing

    Published: 5/12/2016
14. Digital Health Device Seeks to Push Beyond Cannabis to Test Food, Air, and Water

    Published: 5/5/2016
15. Why the Cancer Moonshot Offers a Chance to Rethink Funding Priorities

    Published: 4/28/2016
16. Medtronic Advances Toward an Artificial Pancreas

    Published: 4/21/2016
17. Using Real-Time Data to Detect HIV Outbreaks

    Published: 4/14/2016
18. Why Pharma Needs to Forge New Drug Pricing Models

    Published: 4/7/2016
19. Gensight Targets Gene Therapy on Diseases that Blind

    Published: 3/31/2016
20. A Vial Problem: How We Waste $3 Billion of Cancer Drugs a Year

    Published: 3/24/2016